VAIA
AGIO icon

Virtus Alternative Investment Advisers’s Agios Pharmaceuticals AGIO Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-154
Closed -$7K – 4
2020
Q4 		$7K Sell
154
-148
-49% -$5.85K 0.1% 103
2020
Q3 		$11K Buy
+302
New +$13.2K 0.2% 86

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtus Alternative Investment Advisers's AGIO Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 154 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in AGIO in Q3 2020 and held it in 2 quarters. The position peaked at $11K in Q3 2020. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 154 Agios Pharmaceuticals shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in Agios Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Virtus Alternative Investment Advisers's Agios Pharmaceuticals position peaked at $11K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.